DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter ...

Fintel reports that on March 14, 2025, Stifel upgraded their outlook for Danaher (NYSE:DHR) from Hold to Buy. Analyst Price ...

Shares of Danaher Corp. DHR slid 1.28% to $212.07 Friday, on what proved to be an all-around positive trading session for the ...

Why Is Danaher Corporation’s Stock Showing Market Fluctuations?

Shares of Danaher Corp. DHR slipped 3.23% to $205.23 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...

We recently published a list of Why These 15 Big-Cap Stocks Are Plunging So Far in 2025. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other ...

I’m Dan Brennan, I follow tools and diagnostics. Pleased to be joined with me on stage, CEO of Danaher, Rainer Blair. So Rainer, welcome. Great. Thanks for that. Well, 2024 finished essentially ...

The Rising Need for Efficient and Effective Drug Discoveries Worldwide is Expected to Create Lucrative Growth Opportunities in the Market.

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks. Bourgeon Capital Management LLC is an investment advisory firm headquartered ...